Nomura Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.2M | Buy |
632,863
+475,163
| +301% | +$12.4M | 0.02% | 431 |
|
|
2026
Q1 | $4.43M | Sell |
157,700
-154,473
| -49% | -$4.11M | 0.01% | 679 |
|
|
2025
Q4 | $7.77M | Sell |
312,173
-111,553
| -26% | -$2.81M | 0.01% | 627 |
|
|
2025
Q3 | $10.8M | Buy |
423,726
+16,157
| +4% | +$399K | 0.02% | 502 |
|
|
2025
Q2 | $9.88M | Buy |
407,569
+237,351
| +139% | +$5.54M | 0.02% | 404 |
|
|
2025
Q1 | $4.31M | Sell |
170,218
-450,031
| -73% | -$11.8M | 0.01% | 763 |
|
|
2024
Q4 | $16.5M | Buy |
620,249
+366,077
| +144% | +$9.93M | 0.02% | 381 |
|
|
2024
Q3 | $7.36M | Sell |
254,172
-42,075
| -14% | -$1.23M | 0.02% | 530 |
|
|
2024
Q2 | $8.29M | Sell |
296,247
-36,538
| -11% | -$1.01M | 0.02% | 513 |
|
|
2024
Q1 | $9.23M | Buy |
332,785
+7,451
| +2% | +$207K | 0.02% | 456 |
|
|
2023
Q4 | $9.37M | Sell |
325,334
-689,067
| -68% | -$20.8M | 0.03% | 468 |
|
|
2023
Q3 | $33.6M | Buy |
1,014,401
+461,110
| +83% | +$16.3M | 0.1% | 145 |
|
|
2023
Q2 | $20.3M | Buy |
553,291
+502,878
| +998% | +$19.6M | 0.05% | 217 |
|
|
2023
Q1 | $2.06M | Sell |
50,413
-247,744
| -83% | -$10.7M | 0.01% | 805 |
|
|
2022
Q4 | $15.2M | Buy |
298,157
+168,794
| +130% | +$8.09M | 0.06% | 226 |
|
|
2022
Q3 | $5.76M | Buy |
129,363
+48,014
| +59% | +$2.33M | 0.02% | 504 |
|
|
2022
Q2 | $4.2M | Sell |
81,349
-40,837
| -33% | -$2.08M | 0.01% | 601 |
|
|
2022
Q1 | $6.33M | Sell |
122,186
-335,849
| -73% | -$17.4M | 0.02% | 538 |
|
|
2021
Q4 | $26.8M | Buy |
458,035
+339,395
| +286% | +$16.8M | 0.07% | 212 |
|
|
2021
Q3 | $5.12M | Sell |
118,640
-16,929
| -12% | -$750K | 0.01% | 616 |
|
|
2021
Q2 | $5.31M | Sell |
135,569
-126,780
| -48% | -$4.93M | 0.01% | 559 |
|
|
2021
Q1 | $9.5M | Sell |
262,349
-179,777
| -41% | -$6.38M | 0.02% | 370 |
|
|
2020
Q4 | $16.4M | Sell |
442,126
-1,057,354
| -71% | -$38.8M | 0.03% | 315 |
|
|
2020
Q3 | $52.1M | Sell |
1,499,480
-169,264
| -10% | -$5.93M | 0.11% | 120 |
|
|
2020
Q2 | $51.8M | Buy |
1,668,744
+726,473
| +77% | +$24.7M | 0.18% | 76 |
|
|
2020
Q1 | $29M | Sell |
942,271
-514,654
| -35% | -$17.5M | 0.12% | 94 |
|
|
2019
Q4 | $53.9M | Buy |
1,456,925
+1,122,593
| +336% | +$40M | 0.2% | 85 |
|
|
2019
Q3 | $11.3M | Buy |
334,332
+68,846
| +26% | +$2.5M | 0.04% | 293 |
|
|
2019
Q2 | $11M | Buy |
265,486
+252,587
| +1,958% | +$10M | 0.05% | 301 |
|
|
2019
Q1 | $522K | Sell |
12,899
-545,007
| -98% | -$21.8M | ﹤0.01% | 914 |
|
|
2018
Q4 | $23M | Buy |
557,906
+529,357
| +1,854% | +$22M | 0.09% | 174 |
|
|
2018
Q3 | $1.19M | Sell |
28,549
-541,743
| -95% | -$20.9M | ﹤0.01% | 873 |
|
|
2018
Q2 | $19.6M | Sell |
570,292
-291,724
| -34% | -$9.97M | 0.06% | 241 |
|
|
2018
Q1 | $29.1K | Buy |
862,016
+365,404
| +74% | +$12.6M | 0.05% | 199 |
|
|
2017
Q4 | $17M | Sell |
496,612
-1,316,416
| -73% | -$44.9M | 0.03% | 329 |
|
|
2017
Q3 | $61.3M | Sell |
1,813,028
-82,780
| -4% | -$2.66M | 0.13% | 89 |
|
|
2017
Q2 | $60.1M | Buy |
1,895,808
+889,395
| +88% | +$28M | 0.15% | 81 |
|
|
2017
Q1 | $32.7M | Sell |
1,006,413
-707,716
| -41% | -$22.3M | 0.08% | 111 |
|
|
2016
Q4 | $52.9M | Buy |
1,714,129
+44,429
| +3% | +$1.36M | 0.13% | 101 |
|
|
2016
Q3 | $53.6M | Buy |
1,669,700
+779,794
| +88% | +$26.1M | 0.15% | 84 |
|
|
2016
Q2 | $29.5M | Buy |
889,906
+376,296
| +73% | +$12M | 0.1% | 114 |
|
|
2016
Q1 | $14.5M | Sell |
513,610
-1,164,994
| -69% | -$33.3M | 0.05% | 161 |
|
|
2015
Q4 | $51.4M | Buy |
1,678,604
+1,322,051
| +371% | +$41.6M | 0.14% | 70 |
|
|
2015
Q3 | $10.6M | Sell |
356,553
-283,795
| -44% | -$9.1M | 0.04% | 228 |
|
|
2015
Q2 | $20.3M | Buy |
640,348
+470,651
| +277% | +$15.3M | 0.06% | 153 |
|
|
2015
Q1 | $5.55M | Sell |
169,697
-609,411
| -78% | -$19.4M | 0.02% | 359 |
|
|
2014
Q4 | $23M | Sell |
779,108
-148,729
| -16% | -$4.26M | 0.06% | 193 |
|
|
2014
Q3 | $26.1M | Buy |
927,837
+384,461
| +71% | +$10.8M | 0.07% | 230 |
|
|
2014
Q2 | $15.3M | Sell |
543,376
-789,812
| -59% | -$22.5M | ﹤0.01% | 336 |
|
|
2014
Q1 | $40.5M | Buy |
1,333,188
+675,167
| +103% | +$20.1M | 0.01% | 166 |
|
|
2013
Q4 | $19.1M | Sell |
658,021
-595,364
| -48% | -$17.3M | 0.09% | 133 |
|
|
2013
Q3 | $34.1M | Sell |
1,253,385
-484,196
| -28% | -$13.2M | 0.21% | 85 |
|
|
2013
Q2 | $46.4M | Buy |
+1,737,581
| New | +$48M | 0.38% | 45 |
|
Other funds holding PFE
Nomura Holdings's PFE Position: Q2 2026 in Review
Nomura Holdings increased its Pfizer (PFE) stake by 301% in Q2 2026, buying an estimated $12.4M and bringing the position to 632,863 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #431.
Nomura Holdings first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $61.3M in Q3 2017. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Nomura Holdings held 632,863 shares of Pfizer worth $15.2M as of Q2 2026.
- Nomura Holdings bought 475,163 Pfizer shares in Q2 2026, an estimated $12.4M.
- Pfizer made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #431 holding.
- Nomura Holdings first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Nomura Holdings's Pfizer position peaked at $61.3M in Q3 2017.
- 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.